NeuroBo CEO Gil Price resigns; Joseph Hooker named Interim CEO

MetaVia Inc.

Gil Price resigned as CEO and President effective Jan 12, 2023; resignation not due to disagreement.
Joseph Hooker appointed Interim CEO, President, and Principal Financial and Accounting Officer.
Hooker brings ~40 years pharma experience; previously at X4 Pharma, Biogen, Novartis.
Board to initiate permanent CEO search with executive search firm.
Company advancing DA-1241 and DA-1726; completed $32.3M financing in Nov 2022.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Joseph Hooker

Interim Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer

MTVA · MetaVia Inc.

Effective: 2023-01-12
Filed: January 18, 2023, 6:59 PM ET

On January 12, 2023, the Board appointed Joseph Hooker as the Company’s Interim Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer, effective as of January 12 , 2023.

Departed

Gil Price

Chief Executive Officer and President

MTVA · MetaVia Inc.

Effective: 2023-01-12
Successor: Joseph Hooker
Filed: January 18, 2023, 6:59 PM ET

On January 12, 2023, Gil Price, M.D. resigned as Chief Executive Officer and President of NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company” ), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Joseph Hooker was appointed as Interim Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer at MetaVia Inc..

Action: appointed
Role: Interim Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer

Exact text from the filing

On January 12, 2023, the Board appointed Joseph Hooker as the Company’s Interim Chief Executive Officer, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer, effective as of January 12 , 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Gil Price resigned as Chief Executive Officer and President at MetaVia Inc..

Action: resigned
Role: Chief Executive Officer and President

Exact text from the filing

On January 12, 2023, Gil Price, M.D. resigned as Chief Executive Officer and President of NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company” ), effective immediately.

View on SEC.gov

MetaVia Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-004461

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.